USA - engelsk - NLM (National Library of Medicine)

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - 50% and 70% dextrose injection, usp (concentrated dextrose in water) in pharmacy bulk packages are indicated for use with automated compounding devices for preparing intravenous nutritional admixtures in the pharmacy. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present nor in the presence of delirium tremens if the patient is already dehydrated. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

USA - engelsk - NLM (National Library of Medicine)

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - 50% dextrose injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. the solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. slow infusion of hypertonic solutions is essential to ensure proper utilization of dextrose and avoid production of hyperglycemia. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

USA - engelsk - NLM (National Library of Medicine)

international medication systems, limited - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - 50% dextrose injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels.     the solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. slow infusion of hypertonic solutions is essential to ensure proper utilization of dextrose and avoid production of hyperglycemia. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

USA - engelsk - NLM (National Library of Medicine)

medical purchasing solutions, llc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - 50% dextrose injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels.     the solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. slow infusion of hypertonic solutions is essential to ensure proper utilization of dextrose and avoid production of hyperglycemia. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

USA - engelsk - NLM (National Library of Medicine)

b. braun medical inc. - dextrose, unspecified form (unii: iy9xdz35w2) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose 5 g in 100 ml - these intravenous solutions are indicated for use in adults and pediatric patients as sources of calories and water for hydration. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products. there is no specific pediatric dose. the dose is dependent on weight, clinical condition, and laboratory results. follow recommendations of appropriate pediatric reference text. (see warnings and precautions .)

USA - engelsk - NLM (National Library of Medicine)

b. braun medical inc. - dextrose, unspecified form (unii: iy9xdz35w2) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - dextrose 2.5 g in 100 ml - these intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories and water for hydration. these solutions are contraindicated where the administration of sodium or chloride could be clinically detrimental. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

Singapore - engelsk - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous; sodium chloride - injection - 5 g/100 ml - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous 5 g/100 ml; sodium chloride 200 mg/100 ml

Singapore - engelsk - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous; sodium chloride - injection - 5 g/100 ml - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous 5 g/100 ml; sodium chloride 450 mg/100 ml

Singapore - engelsk - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous; sodium chloride - injection - 5 g/100 ml - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous 5 g/100 ml; sodium chloride 0.9 g/100 ml

Singapore - engelsk - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous - injection - 5 g/100 ml - dextrose anhydrous 4.5 g/100 ml eqv dextrose hydrous 5 g/100 ml